GREGORY BERGER: Open Payments
NPI 1609406453 · CAMDEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,173 in 62 payments from 18 companies in 2025. Trend: 2023 $767 · 2024 $1,639 · 2025 $1,173
Food & beverage: $1,173
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $245 |
| Lilly USA, LLC | 10 | $184 |
| AstraZeneca Pharmaceuticals LP | 8 | $166 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| ABBVIE INC. | 4 | $80 |
| Lundbeck LLC | 3 | $60 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Corcept Therapeutics | 2 | $39 |
| Kowa Pharmaceuticals America, Inc. | 2 | $36 |
Products named: MOUNJARO, REXULTI, PREVNAR 20, ELIQUIS, AIRSUPRA, FARXIGA, UBRELVY, SHINGRIX.
Industry payments across SC — which companies pay providers there.
